Jane Street
INO icon

Jane Street’s Inovio Pharmaceuticals INO Stock Holding History

Jane Street’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.4K Sell
30,691
-27,698
-47% -$45.6K ﹤0.01% 10951
2025
Q4 		$102K Buy
58,389
+26,283
+82% +$57.9K ﹤0.01% 10183
2025
Q3 		$75.1K Sell
32,106
-7,577
-19% -$14.5K ﹤0.01% 10236
2025
Q2 		$80.8K Buy
39,683
+27,329
+221% +$52.4K ﹤0.01% 9042
2025
Q1 		$20.1K Sell
12,354
-27,350
-69% -$54.9K ﹤0.01% 9151
2024
Q4 		$72.7K Buy
39,704
+21,512
+118% +$95.2K ﹤0.01% 8873
2024
Q3 		$105K Sell
18,192
-3,839
-17% -$31.7K ﹤0.01% 8977
2024
Q2 		$178K Sell
22,031
-9,824
-31% -$103K ﹤0.01% 8482
2024
Q1 		$442K Sell
31,855
-6,629
-17% -$57.2K ﹤0.01% 6891
2023
Q4 		$236K Buy
38,484
+16,096
+72% +$79.5K ﹤0.01% 7985
2023
Q3 		$105K Sell
22,388
-243,952
-92% -$1.35M ﹤0.01% 7927
2023
Q2 		$1.43M Buy
266,340
+188,497
+242% +$1.52M ﹤0.01% 4662
2023
Q1 		$766K Buy
77,843
+52,043
+202% +$887K ﹤0.01% 5540
2022
Q4 		$483K Buy
25,800
+22,477
+676% +$509K ﹤0.01% 6190
2022
Q3 		$69K Sell
3,323
-8,547
-72% -$219K ﹤0.01% 8804
2022
Q2 		$246K Sell
11,870
-14,072
-54% -$397K ﹤0.01% 7899
2022
Q1 		$1.12M Buy
25,942
+17,172
+196% +$774K ﹤0.01% 5901
2021
Q4 		$525K Buy
8,770
+3,937
+81% +$315K ﹤0.01% 7168
2021
Q3 		$415K Buy
4,833
+2,089
+76% +$210K ﹤0.01% 7616
2021
Q2 		$306K Sell
2,744
-926
-25% -$88.9K ﹤0.01% 8111
2021
Q1 		$409K Sell
3,670
-34,370
-90% -$4.52M ﹤0.01% 7156
2020
Q4 		$4.04M Buy
38,040
+6,888
+22% +$917K ﹤0.01% 2402
2020
Q3 		$4.34M Sell
31,152
-40,951
-57% -$8.54M ﹤0.01% 2010
2020
Q2 		$23.3M Buy
72,103
+70,813
+5,489% +$11.4M 0.02% 673
2020
Q1 		$115K Buy
+1,290
New +$79.5K ﹤0.01% 4893
2019
Q4 		– Sell
-2,483
Closed -$61K – 5390
2019
Q3 		$61K Sell
2,483
-5,322
-68% -$162K ﹤0.01% 4855
2019
Q2 		$275K Buy
+7,805
New +$310K ﹤0.01% 4315
2018
Q4 		– Sell
-984
Closed -$66K – 5307
2018
Q3 		$66K Buy
+984
New +$54.8K ﹤0.01% 4901
2018
Q2 		– Sell
-1,310
Closed -$74K – 5269
2018
Q1 		$74K Buy
1,310
+81
+7% +$4.38K ﹤0.01% 4644
2017
Q4 		$61K Buy
+1,229
New +$76.2K ﹤0.01% 4409
2016
Q3 		– Sell
-1,405
Closed -$156K – 4253
2016
Q2 		$156K Buy
1,405
+101
+8% +$12.3K ﹤0.01% 3817
2016
Q1 		$136K Buy
+1,304
New +$101K ﹤0.01% 3820
2015
Q4 		– Sell
-1,915
Closed -$133K – 4210
2015
Q3 		$133K Buy
1,915
+151
+9% +$13.2K ﹤0.01% 3312
2015
Q2 		$173K Buy
+1,764
New +$188K ﹤0.01% 3311
2014
Q3 		– Sell
-6,496
Closed -$843K – 2798
2014
Q2 		$843K Sell
6,496
-2,802
-30% -$331K 0.01% 1020
2014
Q1 		$1.49M Buy
9,298
+8,297
+829% +$1.19M 0.02% 707
2013
Q4 		$139K Buy
+1,001
New +$100K ﹤0.01% 2120

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's INO Position: Q1 2026 in Review

Jane Street reduced its Inovio Pharmaceuticals (INO) stake by 47% in Q1 2026, selling an estimated $45.6K and leaving 30,691 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #10951.

Jane Street first reported a position in INO in Q4 2013 and has held it in 37 quarters since. The position peaked at $23.3M in Q2 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Jane Street held 30,691 shares of Inovio Pharmaceuticals worth $53.4K as of Q1 2026.
  • Jane Street sold 27,698 Inovio Pharmaceuticals shares in Q1 2026, an estimated $45.6K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10951 holding.
  • Jane Street first reported a position in Inovio Pharmaceuticals in Q4 2013 and has held it in 37 quarters since.
  • Jane Street's Inovio Pharmaceuticals position peaked at $23.3M in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.